Contact
searchSearch
HMP Global
Quiz

Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata

Riya Gandhi, MA
03/12/2026

 

© 2026 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Dermatology Learning Network or HMP Global, their employees, and affiliates.

Related Content

Dr Brett King
Videos
Expectations for JAK Inhibitor Treatment of Alopecia Areata
03/04/2026
Brett A. King, MD, PhD
Oral JAK inhibitors are appropriate for moderate or rapidly progressive alopecia areata, with regrowth often requiring 6 to 12 months and careful tapering, and failure of one agent not predicting failure of another.
Oral JAK inhibitors are appropriate for moderate or rapidly progressive alopecia areata, with regrowth often requiring 6 to 12 months and careful tapering, and failure of one agent not predicting failure of another.
Oral JAK inhibitors are...
03/04/2026
The Dermatologist
Quiz
Clinical Trial Evaluation of Eyebrow and Eyelash Regrowth in AA
02/05/2026
Riya Gandhi, MA
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how...
02/05/2026
The Dermatologist
Quiz
Psychological and Functional Impact of Eyebrow and Eyelash Loss in AA
02/05/2026
Riya Gandhi, MA
Assess the nuanced emotional and functional burden of eyebrow and eyelash loss in AA patients and how it differs from scalp hair loss in clinical practice.
Assess the nuanced emotional and functional burden of eyebrow and eyelash loss in AA patients and how it differs from scalp hair loss in clinical practice.
Assess the nuanced emotional and...
02/05/2026
The Dermatologist
Melissa Piliang
Videos
Managing Eyebrow & Eyelash Loss in Alopecia Areata: Emotional Impact & Treatment Insights
02/01/2026
Melissa Piliang, MD
In an insightful conversation with Dr Melissa Piliang, we explore how eyebrow and eyelash loss affects patients’ quality of life, advancements in treatment options, and how new clinical trials are offering hope for patients.
In an insightful conversation with Dr Melissa Piliang, we explore how eyebrow and eyelash loss affects patients’ quality of life, advancements in treatment options, and how new clinical trials are offering hope for patients.
In an insightful conversation...
02/01/2026
The Dermatologist

Popular Articles

psoriasis
News
Molecular Commonalities Between Psoriasis and Obesity
04/11/2024
Jessica Garlewicz
Researchers aimed to explore the common inflammatory mechanisms underlying the high comorbidity between psoriasis and obesity.
Researchers aimed to explore the common inflammatory mechanisms underlying the high comorbidity between psoriasis and obesity.
Researchers aimed to explore the...
04/11/2024
The Dermatologist
merola
Conference Coverage
The Impact of Topical PDE-4 Inhibitors in Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
05/08/2024
Riya Gandhi, MA
During his session at Spring Dermatology Week 2024, Dr Joseph Merola illuminated the potential of topical phosphodiesterase-4 inhibitors in the management of atopic dermatitis, seborrheic dermatitis, and psoriasis.
During his session at Spring Dermatology Week 2024, Dr Joseph Merola illuminated the potential of topical phosphodiesterase-4 inhibitors in the management of atopic dermatitis, seborrheic dermatitis, and psoriasis.
During his session at Spring...
05/08/2024
The Dermatologist
psoriasis
News
Shared Biomarkers and Pathways in Psoriasis and Cervical Squamous Cell Carcinoma
06/13/2024
Jessica Garlewicz
Researchers utilized the GSE63514 CESC dataset from the Gene Expression Omnibus and combined 2 psoriasis datasets (GSE13355 and GSE14905) into a single comprehensive dataset after adjusting for batch effects.
Researchers utilized the GSE63514 CESC dataset from the Gene Expression Omnibus and combined 2 psoriasis datasets (GSE13355 and GSE14905) into a single comprehensive dataset after adjusting for batch effects.
Researchers utilized the...
06/13/2024
The Dermatologist
Cover Story
Shared Decision-Making for Older Adult Dermatology Patients
08/05/2024
Jaya Manjunath
This case-based discussion highlights the importance of integrating clinical knowledge with the individualized patient scenario.
This case-based discussion highlights the importance of integrating clinical knowledge with the individualized patient scenario.
This case-based discussion...
08/05/2024
The Dermatologist
acne
News
Targeted Precision Cryotherapy Treatment for Acne Lesions
09/11/2024
Jessica Garlewicz
This pilot clinical trial investigated the feasibility and efficacy of precision cryotherapy as an alternative treatment for acne vulgaris.
This pilot clinical trial investigated the feasibility and efficacy of precision cryotherapy as an alternative treatment for acne vulgaris.
This pilot clinical trial...
09/11/2024
The Dermatologist
cover March 2026

Current Issue

March 2026
Volume 34
Issue 2
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist
psoriasis
Quiz
Quiz: Misdiagnosis of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized...
03/02/2026
The Dermatologist
Quiz
Allergic Disease Progression: Genetics and Environment
02/26/2026
Riya Gandhi, MA
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between...
02/26/2026
The Dermatologist
Quiz
Early Intervention Strategies in Pediatric Atopic Dermatitis
02/26/2026
Riya Gandhi, MA
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of...
02/26/2026
The Dermatologist
Quiz
Air Pollution and Atopic Disease: Evaluating Epidemiologic Evidence
02/26/2026
Riya Gandhi, MA
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the...
02/26/2026
The Dermatologist
Quiz
Clinical Trial Evaluation of Eyebrow and Eyelash Regrowth in AA
02/05/2026
Riya Gandhi, MA
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how...
02/05/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use